Stephanie Yee-Guardino*, Kate Gowans*, Belinda Yen-Lieberman†, Pamela Berk†, Debra Kohn†, Fu-Zhang Wang†1, Lara Danziger-Isakov*†, Camille Sabella*†, Sarah Worley†, Philip E. Pellett†2 , and Johanna Goldfarb*†
Author affiliations: *Cleveland Clinic Children’s Hospital, Cleveland, Ohio, USA; †Cleveland Clinic, Cleveland, Ohio, USA; 1Current affiliation: University of North Carolina, Chapel Hill, North Carolina, USA; 2Current affiliation: Wayne State University School of Medicine, Detroit, Michigan, USA;
Figure. Temporal relationship between detection of β-herpesvirus (βHV) and onset of immune suppression. Time of collection of each study specimen is indicated relative to onset of immune suppression for cancer patients and solid-organ transplant recipients. HHV, human herpesvirus; CMV, cytomegalovirus.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.